Building an AI Governance Framework for Healthcare Organisations

Author: Eunoia Consulting Co. | Published: May 4, 2026

A comprehensive guide to designing and implementing a robust AI governance framework for healthcare organisations — covering policy, compliance, risk management, and clinical validation.

Key Takeaways

  • Healthcare AI governance requires a dedicated policy layer covering accountability, risk, and clinical validation — not just IT security.
  • FDA SaMD classification determines whether your AI tool is a medical device subject to regulatory clearance.
  • Algorithmic bias audits must be conducted before deployment and at regular intervals post-deployment.
  • A documented AI incident response plan is now a baseline expectation from regulators and payers.
  • Organisations that establish governance frameworks early reduce AI-related liability by an estimated 40–60%.

What Is AI Governance in Healthcare?

AI governance in healthcare refers to the policies, processes, and structures that organisations put in place to ensure their artificial intelligence systems are safe, effective, ethical, and compliant with applicable regulations. As AI becomes embedded in clinical workflows — from diagnostic imaging to predictive risk scoring — the need for robust governance has never been more urgent.

Without a formal governance framework, healthcare organisations face significant risks: regulatory penalties under HIPAA and emerging AI legislation, patient safety incidents from unvalidated models, and reputational damage from opaque or biased AI decisions.

The Five Pillars of Healthcare AI Governance

1. Policy and Accountability

Every AI governance framework begins with clear policies that define who is responsible for AI decisions within the organisation. This includes designating an AI governance committee or officer, establishing escalation pathways for AI-related incidents, and defining the criteria by which AI systems are approved for clinical use.

Accountability structures should mirror existing clinical governance frameworks — AI should not exist in a regulatory vacuum separate from your broader quality and safety systems.

2. Risk Classification and Assessment

Not all AI systems carry the same risk. The FDA's Software as a Medical Device (SaMD) framework classifies AI-powered clinical tools by the severity of harm that could result from incorrect output. Your governance framework should adopt a similar tiered approach: